Insider · CIK 0001825192

Jalota Deepika

Reports to the SEC for 1 company · PRINCETON, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001825192

Forms 4 and 5

Insider transactions

19 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-05	PMVPPMV Pharmaceuticals, Inc. · Employee Stock Option (right to buy)A Award	Chief Development Officer	AAward	+303K sh	—	—	303,310
2025-07-01	PMVPPMV Pharmaceuticals, Inc.S Sale	Chief Development Officer	SSale	−33.1K sh	$1.06	−$35.2K	89,959
2025-03-03	PMVPPMV Pharmaceuticals, Inc. · Employee Stock Option (right to buy)A Award	Chief Development Officer	AAward	+300K sh	—	—	300,000
2024-09-11	PMVPPMV Pharmaceuticals, Inc.S Sale	Chief Development Officer	SSale	−7,218 sh	$1.50	−$10.9K	118,283
2024-08-13	PMVPPMV Pharmaceuticals, Inc. · Employee Stock Option (right to buy)D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−22.7K sh	—	—	0
2024-08-13	PMVPPMV Pharmaceuticals, Inc. · Employee Stock Option (right to buy)D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−68.1K sh	—	—	0
2024-08-13	PMVPPMV Pharmaceuticals, Inc. · Employee Stock Option (right to buy)A Award	Chief Development Officer	AAward	+90.8K sh	—	—	90,774
2024-08-13	PMVPPMV Pharmaceuticals, Inc. · Employee Stock Option (right to buy)D Disposition to Issuer	Chief Development Officer	DDisposition to Issuer	−125K sh	—	—	0
2024-08-13	PMVPPMV Pharmaceuticals, Inc. · Employee Stock Option (right to buy)A Award	Chief Development Officer	AAward	+125K sh	—	—	125,000
2024-01-18	PMVPPMV Pharmaceuticals, Inc.A Award	Chief Development Officer	AAward	+95.6K sh	—	—	125,501
2024-01-18	PMVPPMV Pharmaceuticals, Inc. · Employee Stock Option (right to buy)A Award	Chief Development Officer	AAward	+225K sh	—	—	225,095
2023-09-15	PMVPPMV Pharmaceuticals, Inc.S Sale	Chief Development Officer	SSale	−4,104 sh	$6.62	−$27.2K	29,946
2023-05-12	PMVPPMV Pharmaceuticals, Inc. · Employee Stock Option (right to buy)A Award	Chief Development Officer	AAward	+125K sh	—	—	125,000
2022-09-09	PMVPPMV Pharmaceuticals, Inc.A Award	Chief Development Officer	AAward	+34.1K sh	—	—	34,050
2022-02-10	PMVPPMV Pharmaceuticals, Inc. · Employee Stock Option (right to buy)A Award	Chief Development Officer	AAward	+68.1K sh	—	—	68,100
2021-08-17	PMVPPMV Pharmaceuticals, Inc.M Exercise/Conversion	Chief Development Officer	MExercise/Conversion	+2,896 sh	$3.53	+$10.2K	2,896
2021-08-17	PMVPPMV Pharmaceuticals, Inc.S Sale	Chief Development Officer	SSale	−2,896 sh	$33.78	−$97.8K	0
2021-08-17	PMVPPMV Pharmaceuticals, Inc. · Stock option (right to buy)M Exercise/Conversion	Chief Development Officer	MExercise/Conversion	−2,896 sh	—	—	87,320
2021-05-12	PMVPPMV Pharmaceuticals, Inc. · Employee Stock Option (right to buy)A Award	Chief Development Officer	AAward	+22.7K sh	—	—	22,674

Recent filings

Accepted (ET)
Mar 94
Jalota Deepika0001825192-26-000002
SEC(opens sec.gov)
Jul 34
Jalota Deepika0001415889-25-019384
SEC(opens sec.gov)
Mar 54
Jalota Deepika0001415889-25-007073
SEC(opens sec.gov)
Oct 34
Jalota Deepika0001415889-24-024627
SEC(opens sec.gov)
Sep 124
Jalota Deepika0001415889-24-023313
SEC(opens sec.gov)
Jan 224
Jalota Deepika0001209191-24-001999
SEC(opens sec.gov)
Sep 184
Jalota Deepika0001209191-23-049759
SEC(opens sec.gov)
May 154
Jalota Deepika0001209191-23-029612
SEC(opens sec.gov)
Sep 134
Jalota Deepika0001209191-22-049694
SEC(opens sec.gov)
Feb 284
Jalota Deepika0001209191-22-013576
SEC(opens sec.gov)
Aug 184
Jalota Deepika0001209191-21-052248
SEC(opens sec.gov)
Jun 84
Jalota Deepika0001209191-21-039038
SEC(opens sec.gov)

Companies

PMV Pharmaceuticals, Inc.Chief Development OfficerPMVP

Address

C/O PMV PHARMACEUTICALS, INC. 400 ALEXANDER PARK DRIVE, SUITE 301

PRINCETON, NJ, 08540